These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2656479)

  • 1. Targeting of liposomes to liver cells.
    Scherphof GL; Spanjer HH; Derksen JT; Lázár G; Roerdink FH
    Horiz Biochem Biophys; 1989; 9():281-91. PubMed ID: 2656479
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomes as carriers of DNA.
    Nicolau C; Cudd A
    Crit Rev Ther Drug Carrier Syst; 1989; 6(3):239-71. PubMed ID: 2692845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of drugs to the liver.
    Meijer DK; Molema G
    Semin Liver Dis; 1995 Aug; 15(3):202-56. PubMed ID: 7491504
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
    Chow DD; Essien HE; Padki MM; Hwang KJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):506-13. PubMed ID: 2918467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.
    Torchilin VP
    Adv Drug Deliv Rev; 2005 Jan; 57(1):95-109. PubMed ID: 15518923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, liposomes with L-DOPA and "empty" liposomes on the phospholipid composition of the murine liver].
    Podgornyĭ GN; Namestnikova IV; Sliusar' NN
    Eksp Klin Farmakol; 1999; 62(1):41-4. PubMed ID: 10198765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of therapeutics to the liver: liposomes and viral vectors.
    Di Campli C; Wu J; Zern MA
    Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
    Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
    J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of cardiomyocyte-targeting liposomes and their targeting ability in vitro].
    Chen Y; Deng YJ; Hao YL; Wang ZY; Sheng J
    Yao Xue Xue Bao; 2005 Jun; 40(6):568-72. PubMed ID: 16144327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes.
    Longman SA; Tardi PG; Parr MJ; Choi L; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1177-84. PubMed ID: 8531079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes, a tale of drug targeting.
    Gregoriadis G
    J Drug Target; 1993; 1(1):3-6. PubMed ID: 8069542
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone.
    Sato Y; Murase K; Kato J; Kobune M; Sato T; Kawano Y; Takimoto R; Takada K; Miyanishi K; Matsunaga T; Takayama T; Niitsu Y
    Nat Biotechnol; 2008 Apr; 26(4):431-42. PubMed ID: 18376398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated liposomes as oligodeoxynucleotides carrier for hepatocyte-selective targeting.
    Yu F; Jiang T; Zhang J; Cheng L; Wang S
    Pharmazie; 2007 Jul; 62(7):528-33. PubMed ID: 17718195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The distribution of azidothymidine palmitate galactosylated liposomes in mice].
    Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L
    Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis.
    Khalil RM; Murad FE; Yehia SA; El-Ridy MS; Salama HA
    Pharmazie; 1996 Mar; 51(3):182-4. PubMed ID: 8900871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model.
    Codde JP; Lumsden AJ; Napoli S; Burton MA; Gray BN
    Anticancer Res; 1993; 13(2):539-43. PubMed ID: 8517669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Zhao W; Ma HL; Qi XR
    Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.